Seasonal Influenza Vaccines Therapeutics Market Size, Share, Trends And Forecast To 2032

How big is the Seasonal Influenza Vaccines Therapeutics Market?

According to the report published by Zion Market Research, the global Seasonal Influenza Vaccines Therapeutics Market size was valued at USD 25.04 Billion in 2023 and is predicted to reach USD 43.39 Billion by the end of 2032. The market is expected to grow with a CAGR of 6.3% during the forecast period. The report analyzes the global Seasonal Influenza Vaccines Therapeutics Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Seasonal Influenza Vaccines Therapeutics industry.

Request Free SampleRequest Free Sample

Seasonal Influenza Vaccines Therapeutics Market: Overview

The influenza vaccine is also called the flu shot. It is used to protect against the infection of the influenza virus. An influenza vaccine has a mixture of 3 virus types which include influenza type B virus strain, influenza type A having the H3N2 virus strain, and influenza type A having the H1N1 virus strain. Influenza is a respiratory illness that is contagious and may lead to mild or severe disease. It may lead to the death of the patient. The classification of the influenza virus is done on the basis of the H1N1 (influenza A) virus, H3N2 (influenza A) virus, and one or two influenza B viruses. The symptoms shown by the patients include cough, running nose, headache chills, diarrhea, sore throat, body aches, fatigue, and vomiting.

Seasonal Influenza Vaccines Therapeutics Market: Facts

The Australian Influenza Vaccine Committee (AIVC) has assessed and evaluated the data that is related to the strains of influenza that were present in the regions of Australia and the Southern Hemisphere. On the basis of this review, the AIVC recommended the TGA adopt the September 2016 World Health Organization (WHO) proposals for the strains to be covered by the 2017 seasonal influenza vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Growth Factors

The major factors that are driving the seasonal influenza vaccine therapeutics market are wider coverage of the vaccination, growing disease awareness about influenza, and the rise in the support of the government for immunization purposes against seasonal influenza. There is a huge pipeline of products that are made by the major market players thus making the portfolio of the product strong. The key factors that are restraining the growth of the market are limited production capacity, strict regulations imposed, variable demand, and a high level of required investment.

Request Free SampleRequest Free Sample

Seasonal Influenza Vaccines Therapeutics Market: Segmentation

The global market for seasonal influenza vaccine therapeutics is fragmented into its end-users and the treatment type.

On the basis of the end-user, the global market is segregated into hospitals, clinics, and medicals.

On the basis of the patient type, the market is divided into adolescence, the elderly, pediatrics, and adults.

On the basis of the treatment type, the global market is categorized into antiviral therapies and vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Report Scope

Seasonal Influenza Vaccines Therapeutics Market: Regional Analysis

The regions where the seasonal influenza vaccine therapeutics market is expanded include New Zealand, Taiwan, Hong Kong, India, Japan, Australia, China, the Philippines, Singapore, and Malaysia. In recent years, the market witnessed healthy growth in the countries such as France, Italy, the U.K., the U.S., Germany, Spain, and Japan. In the Asia Pacific region, the Philippines have the most attractive market for seasonal influenza vaccines.

Seasonal Influenza Vaccines Therapeutics Market: Competitive Players

The key market players that are involved in the seasonal influenza vaccines therapeutics market include

• Novartis
• MedImmune
• Solvay
• Hualun Biologicals
• Seqirus
• MedImmune
• GlaxoSmithKline
• CSL
• Sanofi-Pasteur
• Sinovac Biotech
• ID Biomedical Corp
• of Quebec
• Protein Sciences.

The Global Seasonal Influenza Vaccines Therapeutics Market segments are as follows:

By End-User

• Hospitals
• Clinics
• Medicals.

By Patient Type

• Dolescence
• The Elderly
• Pediatrics
• Adults.

By Treatment Type

• Antiviral Therapies
• Vaccines.

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.